Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines Against Symptomatic SARS-CoV-2 Infection and Severe COVID-19 Outcomes in Ontario, Canada-Reference-Cited by-同舟云学术

Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines Against Symptomatic SARS-CoV-2 Infection and Severe COVID-19 Outcomes in Ontario, Canada

Published:2021 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Chung Hannah,He Siyi,Nasreen Sharifa,Sundaram Maria,Buchan Sarah,Wilson Sarah,Chen Branson,Calzavara Andrew,Fell Deshayne,Austin Peter C.,Wilson Kumanan,Schwartz Kevin L.,Brown Kevin A.,Gubbay Jonathan B.,Basta Nicole,Mahmud Salaheddin,Righolt Christiaan,Svenson Lawrence,MacDonald Shannon,Janjua Naveed,Tadrous Mina,Kwong Jeffrey C.,Group Canadian Immunization Research Netw

Publisher

Elsevier BV

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval;Vaccine;2024-11

2. Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5;Frontiers in Immunology;2023-07-13

3. Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19;Frontiers in Immunology;2023-03-22

4. Modeling the spatio‑temporal spread of COVID‑19 cases, recoveries and deaths and effects of partial and full vaccination coverage in Canada;Scientific Reports;2022-10-24

5. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study;BMC Public Health;2022-05-25